Trial: 201812031

STAMP: Surgically Treated Adjuvant Merkel cell carcinoma with Pembrolizumab, a Phase III Trial

Phase

III

Principal Investigator

Ansstas, George

Disease Site

Other Skin

Learn more about this study at: clinicaltrials.gov